Urgent

Suspected bleeding disorder (approach)

Bleeding / coagulation · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A structured approach to the patient with abnormal bleeding. The pattern points to the mechanism: MUCOCUTANEOUS bleeding (petechiae, purpura, epistaxis, menorrhagia, gum/GI bleeding) suggests a PLATELET or vascular/VWF problem, whereas DEEP bleeding (haemarthroses, muscle haematomas, delayed post-surgical bleeding) suggests a COAGULATION FACTOR deficiency. Distinguish an inherited disorder (lifelong, positive family history) from an acquired one (new onset — drugs, liver disease, DIC, acquired inhibitors, vitamin K deficiency).

Red flags

  • Active major or intracranial bleeding
  • Bleeding on anticoagulants/antiplatelets or with liver disease
  • Petechiae/purpura with thrombocytopenia (consider TTP, DIC, acute leukaemia)
  • A strong bleeding or family history despite a normal PT/APTT

Assessment

Differential diagnosis

  • Thrombocytopenia (ITP, DIC, TTP, marrow failure, drugs)
  • Platelet function defect (drugs — antiplatelets, uraemia, inherited)
  • Von Willebrand disease (inherited or acquired)
  • Coagulation factor deficiency (haemophilia A/B, acquired factor inhibitors)
  • Liver disease / vitamin K deficiency / warfarin/DOAC effect
  • Disseminated intravascular coagulation
  • Vascular/connective-tissue causes

Investigations

  • FBC and blood FILM (platelet count and morphology), PT/INR, APTT, fibrinogen
  • Interpret the screen: isolated prolonged APTT → intrinsic factors (VIII/IX/XI) or heparin/inhibitor; isolated prolonged PT → factor VII / early warfarin; BOTH prolonged → common pathway, liver disease, DIC, warfarin, vitamin K deficiency
  • A MIXING STUDY corrects with a factor deficiency but NOT with an inhibitor
  • Targeted tests: von Willebrand studies (VWF:Ag, activity, FVIII), specific factor assays, platelet function tests, D-dimer/fibrinogen for DIC
  • Take a structured bleeding history (± a validated bleeding assessment tool), drug history and family history

Management

  • Resuscitate active bleeding and stop/reverse contributing drugs (antiplatelets, anticoagulants).
  • Send the first-line screen (FBC/film, PT, APTT, fibrinogen) and take a careful bleeding, drug and family history to localise platelet vs factor vs vascular cause.
  • Interpret PT/APTT pattern and use a mixing study to separate factor deficiency from an inhibitor.
  • Give cause-directed therapy: platelets for thrombocytopenic bleeding, vitamin K/PCC for warfarin, factor concentrate for haemophilia, VWF/DDAVP for VWD, and specific reversal for DOACs; TRANEXAMIC ACID as a mucosal-bleeding adjunct.
  • Refer to HAEMATOLOGY for abnormal results, a strong bleeding history with normal screening (e.g. mild VWD or platelet function defect can have a normal PT/APTT), or a suspected inhibitor.

Drugs & doses

Cause-directed: platelets, vitamin K / prothrombin complex concentrate, clotting factor concentrate, VWF/DDAVP, DOAC-specific reversal
Tranexamic acid (mucosal-bleeding adjunct)
Stop/hold antiplatelets and anticoagulants

Disposition

Admit active/serious bleeding; haematology referral for abnormal results or a convincing bleeding history.

Complications & pitfalls

  • Major haemorrhage
  • Missed serious cause (leukaemia, TTP, DIC)
  • Delayed diagnosis of a mild inherited disorder

Exam pearls

  • Pattern first: mucocutaneous bleeding = platelet/VWF; deep/joint bleeding = coagulation factor.
  • A NORMAL PT/APTT does not exclude a bleeding disorder — mild VWD and platelet function defects can have a normal screen.
  • Mixing study: corrects = factor deficiency; fails to correct = an inhibitor.
  • Always take a drug history — antiplatelets/anticoagulants are the commonest cause of new bleeding.

Work up abnormal bleeding by PATTERN (mucocutaneous → platelet/VWF; deep → factor) and by an acquired-vs-inherited history; send FBC/film, PT, APTT and fibrinogen, interpret the pattern (and a mixing study for inhibitors), give cause-directed therapy plus tranexamic acid, and refer to haematology — remembering a normal screen does not exclude mild VWD or a platelet function defect.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.